Ocular Therapeutix Inc.
OCUL | NASDAQ
$6.97
-$0.34 (-4.65%)
At close: Oct 30, 2026, 4:00 PM ET
$7.13
+$0.16 (+2.30%)
Pre-market:
Nov 2, 2026, 8:47 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 51.82M | 63.72M | 58.44M | 51.49M | 43.52M | 17.4M |
Cost of Revenue | 6.57M | 5.63M | 5.28M | 4.54M | 4.41M | 2.08M |
Gross Profit | 45.25M | 58.1M | 53.16M | 46.95M | 39.12M | 15.32M |
Operating Income | -270.02M | -171.78M | -82.38M | -78.65M | -78.04M | -62.85M |
Interest Income | 18.36M | 20.28M | 3.98M | 798K | 33K | 168K |
Pretax Income | -265.94M | -193.51M | -80.74M | -71.04M | -6.55M | -155.64M |
Net Income | -265.94M | -193.51M | -80.74M | -71.04M | -6.55M | -155.64M |
Selling & General & Admin | 118.3M | 102.24M | 74.49M | 72.15M | 67.07M | 49.47M |
Research & Development | 197.1M | 127.64M | 61.06M | 53.46M | 50.08M | 28.69M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 315.39M | 229.88M | 135.54M | 125.61M | 117.15M | 78.17M |
Interest Expense | 11.84M | 13.58M | 11.34M | 7.02M | 6.67M | 6.77M |
Selling & Marketing Expenses | 53.92M | 41.59M | 40.55M | 4.17M | 35.19M | 26.61M |
Cost & Expenses | 321.97M | 235.5M | 140.83M | 130.15M | 121.56M | 80.25M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 187.24M | 158.27M | 79.83M | 76.88M | 76.39M | 60.75M |
Shares Outstanding (Diluted) | 187.24M | 158.27M | 85.6M | 82.64M | 82.16M | 60.75M |
EPS (Basic) | -1.42 | -1.22 | -1.09 | -1.04 | -1.05 | -2.56 |
EPS (Diluted) | -1.42 | -1.22 | -1.02 | -0.97 | -0.98 | -2.56 |
EBITDA | -249.78M | -176.14M | -66.42M | -61.91M | 2.54M | -146.1M |
EBIT | -254.1M | -179.93M | -69.4M | -64.02M | 118K | -148.87M |
Depreciation & Amortization | 4.32M | 3.79M | 2.98M | 2.11M | 2.42M | 2.77M |
Add to Watchlist
Select watchlists to add or remove OCUL